TUE, 20 OCT 2026|
[BRAND]
LATEST
01BAIL DENIED: ‘Dangerous pattern’: Shadrack Sibiya denied bail over threats and wiped cellphone02Mir Raza case: Judicial commission points finger at police’s ‘epic failure’, says he was murdered03Indian military doctrines with 'poor' strategic sense of nuclear realities endanger South Asia: NCA adviser04How have big names fared in the Irish Premiership?05Actor Christina Applegate reveals she was misdiagnosed with multiple sclerosis06Genetic study shows seafarers from Easter Island settled Hawaii07‘Don’t send money home, ask them to elect capable leaders,’ Peter Obi tells UK-based Nigerians08Why O'Sullivan faces battle to stay in world's top 16
Feed/Economy · Finance
Economy · Finance

Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

CNBC · World
Published 20 Oct 2026, 11:50 pm·1 h ago·1 min read
Listen to this story
Read aloud by your device

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.

Read the full story at CNBC · World
cnbc.com
Open ↗

Related

Economy · Finance

Heisman and CFP market watch: Notre Dame new favorites, the Big 12 and Week 7 chaos

48 min ago·ESPN·1 min read
Economy · Finance

China’s hybrid car exports to EU surge by more than 200% as import cap looms

1 h ago·South China Morning Post·1 min read
Economy · Finance

Chinese battery giant CATL hit by profit slowdown as EV headwind fears grow

1 h ago·South China Morning Post·1 min read
Economy · Finance

Apple adds U.S. titanium supplier for iPhone Duo as supply stays tight

1 h ago·CNBC · World·1 min read
Economy · Finance

Eritrea: Eritrea's Migration Economy - Can the Nation Survive Without Forced Remittance?

1 h ago·AllAfrica·1 min read